Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-18

FDA Approved: RUFINAMIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' generic Rufinamide via an ANDA for seizures associated with Lennox-Gastaut syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)